Hepatitis E Diagnostic Tests Market: Opportunities, Company Analysis and Forecast to 2024
A handful of companies dominate the global market for hepatitis E diagnostic tests. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., among them, is the dominant player that accounts for around 30% of market share. The other key players in the market are Fortress Diagnostics, Mikrogen, Biokit SA, MP Biomedicals, Altona Diagnostics, and Fast-track Diagnostics. Competition among them is robust and going forward is slated to intensify further on account of competitive pricing strategies leveraged by them.
View full press release